Skip to main content
. 2014 Dec 1;9(12):e113931. doi: 10.1371/journal.pone.0113931

Figure 1. Body weight, food intake and haematocrit content in sorafenib-treated tumour-bearing mice.

Figure 1

Results are mean ± S.E.M. for 6–8 animals. Food intake represents the total ingestion (g) during the period of the experiment prior to sacrifice, which took place 14 days after tumour inoculation. Final body weight excludes the tumour weight. The haematocrit is expressed in percentage. C: animals without tumour (n = 6); C26: C26 adenocarcinoma-bearing mice (n = 8); C26 Sor: C26 adenocarcinoma-bearing mice treated with sorafenib (n = 8); B16: B16 melanoma-bearing mice (n = 8); B16 Sor: B16 melanoma-bearing mice treated with sorafenib (n = 8); LLC: Lewis lung carcinoma-bearing mice (n = 8); LLC Sor: Lewis lung carcinoma-bearing mice treated with sorafenib (n = 8). Values that are significantly different of the results by one-way analysis of variance (ANOVA), statistically significant differences by post hoc Duncan test. Different letters in superscript indicate significant differences between groups.